1479 related articles for article (PubMed ID: 25452219)
1. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Boellaard R; Delgado-Bolton R; Oyen WJ; Giammarile F; Tatsch K; Eschner W; Verzijlbergen FJ; Barrington SF; Pike LC; Weber WA; Stroobants S; Delbeke D; Donohoe KJ; Holbrook S; Graham MM; Testanera G; Hoekstra OS; Zijlstra J; Visser E; Hoekstra CJ; Pruim J; Willemsen A; Arends B; Kotzerke J; Bockisch A; Beyer T; Chiti A; Krause BJ;
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):328-54. PubMed ID: 25452219
[TBL] [Abstract][Full Text] [Related]
2. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
3. Quantitative FDG PET/CT in the community: experience from interpretation of outside oncologic PET/CT exams in referred cancer patients.
Tahari AK; Wahl RL
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):183-8. PubMed ID: 24314055
[TBL] [Abstract][Full Text] [Related]
4. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
5. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
Dimitrakopoulou-Strauss A; Pan L; Strauss LG
Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
Makris NE; Huisman MC; Kinahan PE; Lammertsma AA; Boellaard R
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1507-15. PubMed ID: 23754762
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
8. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
[TBL] [Abstract][Full Text] [Related]
9. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
Boellaard R; O'Doherty MJ; Weber WA; Mottaghy FM; Lonsdale MN; Stroobants SG; Oyen WJ; Kotzerke J; Hoekstra OS; Pruim J; Marsden PK; Tatsch K; Hoekstra CJ; Visser EP; Arends B; Verzijlbergen FJ; Zijlstra JM; Comans EF; Lammertsma AA; Paans AM; Willemsen AT; Beyer T; Bockisch A; Schaefer-Prokop C; Delbeke D; Baum RP; Chiti A; Krause BJ
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):181-200. PubMed ID: 19915839
[TBL] [Abstract][Full Text] [Related]
10. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
Kitajima K; Suenaga Y; Sugimura K
Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
12. Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0".
Saboury B; Torigian DA; Alavi A
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1430-1; author reply 1432-3. PubMed ID: 20503048
[No Abstract] [Full Text] [Related]
13. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
14. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
[TBL] [Abstract][Full Text] [Related]
15. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
[TBL] [Abstract][Full Text] [Related]
16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis.
De Geeter F; Gykiere P
Hell J Nucl Med; 2016; 19(1):5-6. PubMed ID: 26929934
[TBL] [Abstract][Full Text] [Related]
18. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
Yilmaz S; Aliyev A; Ekmekcioglu O; Ozhan M; Uslu L; Vatankulu B; Sager S; Halaç M; Sönmezoğlu K
Nuklearmedizin; 2015; 54(6):262-71. PubMed ID: 26503832
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
20. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
